-+ 0.00%
-+ 0.00%
-+ 0.00%

XENCOR ANNOUNCES PROFFERED PAPER ORAL PRESENTATION AT ESMO 2026 FOR PHASE 1 CLINICAL STUDY OF XMAB819 IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

Reuters·07/17/2026 13:11:00

Please log in to view news